Drug Profile
Research programme: tissue factor/factor VIIa complex inhibitors - BioCryst/Sunol Molecular
Alternative Names: BCX 3607; BCX 3891Latest Information Update: 02 Apr 2008
Price :
$50
*
At a glance
- Originator BioCryst Pharmaceuticals; Sunol Molecular Corporation
- Developer BioCryst Pharmaceuticals
- Class Small molecules
- Mechanism of Action Factor VIIa inhibitors; Thromboplastin inhibitors; Tissue factor-factor VIIa complex inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Coronary disorders; Thrombosis